Gabelli Funds’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-828,055
Closed -$82.2M 1199
2019
Q3
$82.2M Buy
828,055
+31,630
+4% +$3.01M 0.54% 32
2019
Q2
$73.6M Buy
796,425
+211,098
+36% +$20M 0.47% 45
2019
Q1
$55.2M Buy
+585,327
New +$51.2M 0.35% 77
2017
Q4
Sell
-44,900
Closed -$6.55M 1165
2017
Q3
$6.55M Buy
44,900
+3,000
+7% +$409K 0.04% 505
2017
Q2
$5.44M Sell
41,900
-14,000
-25% -$1.72M 0.03% 537
2017
Q1
$6.96M Buy
55,900
+13,300
+31% +$1.59M 0.04% 471
2016
Q4
$4.93M Sell
42,600
-26,000
-38% -$2.9M 0.03% 553
2016
Q3
$7.17M Buy
68,600
+2,700
+4% +$292K 0.04% 459
2016
Q2
$6.5M Buy
65,900
+11,000
+20% +$1.14M 0.04% 478
2016
Q1
$5.5M Sell
54,900
-11,500
-17% -$1.18M 0.03% 524
2015
Q4
$7.95M Hold
66,400
0.05% 435
2015
Q3
$7.18M Buy
66,400
+19,000
+40% +$2.36M 0.04% 467
2015
Q2
$5.49M Hold
47,400
0.03% 561
2015
Q1
$5.46M Sell
47,400
-2,200
-4% -$263K 0.03% 567
2014
Q4
$5.55M Sell
49,600
-7,800
-14% -$823K 0.03% 571
2014
Q3
$5.44M Buy
57,400
+3,000
+6% +$271K 0.03% 574
2014
Q2
$4.67M Buy
54,400
+4,000
+8% +$304K 0.02% 617
2014
Q1
$3.52M Hold
50,400
0.02% 659
2013
Q4
$4.26M Sell
50,400
-3,200
-6% -$253K 0.02% 602
2013
Q3
$4.13M Hold
53,600
0.02% 599
2013
Q2
$3.13M Buy
+53,600
New +$3.23M 0.02% 627

Other funds holding CELG

Gabelli Funds's CELG Position: Q4 2019 in Review

Gabelli Funds sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 828,055 shares — an estimated $82.2M sold.

Gabelli Funds first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $82.2M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Gabelli Funds reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Gabelli Funds sold 828,055 Celgene Corp shares in Q4 2019, an estimated $82.2M.
  • Gabelli Funds first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Gabelli Funds's Celgene Corp position peaked at $82.2M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gabelli Funds's 13F filing for Q4 2019, filed 14 Feb 2020.